Next Generation News and Research

RSS

Compounds in soy sauce can be 70 times more potent than first-line HIV drug Tenofovir

For HIV patients being treated with anti-AIDS medications, resistance to drug therapy regimens is commonplace. Often, patients develop resistance to first-line drug therapies, such as Tenofovir, and are forced to adopt more potent medications.

6 May 2014

Olympus launches next-generation ENDOCAPSULE 10 System for capsule endoscopy procedures

Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today the commercial availability of its 510(k) cleared, next-generation ENDOCAPSULE 10 System for small bowel capsule endoscopy procedures.

From Evident Corporation - Life Sciences 5 May 2014

ASGE to honor important contributions to field of endoscopy during tenth annual ASGE Crystal Awards

The American Society for Gastrointestinal Endoscopy (ASGE) will honor important contributions to the field of endoscopy during the tenth annual ASGE Crystal Awards on Sunday, May 4, 2014.

5 May 2014

New research shows UK has highest infant mortality rates in Western Europe

The UK has one of the highest rates of death for children under five in western Europe, according to new research published in The Lancet.

2 May 2014

Sleep habits associated with memory in old-age

A new research study led by Brigham and Women's Hospital (BWH) published in The Journal of the American Geriatrics Society in May, shows an association between midlife and later life sleeping habits with memory; and links extreme sleep durations to worse memory in later life. The study suggests that extreme changes in sleep duration from middle age to older age may also worsen memory function.

1 May 2014

Illumina launches VeriSeq PGS for preimplantation genetic screening of embryos

Illumina, Inc. today announced the launch of VeriSeq PGS, a next-generation sequencing solution developed for preimplantation genetic screening of embryos using Illumina's NextSeq 500 and MiSeq® sequencing systems.

From Illumina, Inc. 29 Apr 2014

EGPAF launches new training program to address health care worker shortages in Malawi

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is proud to launch a new training program to address health care worker shortages in Malawi. The program kicked-off today by enrolling students from 21 rural and remote areas of Malawi into a three-year training program to become nurse midwife technicians.

29 Apr 2014

Mayo Clinic launches new gene panel cancer test to help tailor chemotherapy

Mayo Clinic announces the launch of CANCP, a new gene panel cancer test to help tailor chemotherapy to the individual patient based on the unique genomic signature of the patient's tumor.

29 Apr 2014

Voluntis closes €20.75 million ($29 million) Series D financing round

Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.

28 Apr 2014

University of Michigan scientists uncover how cells block mutation-causing activity of junk DNA

There's a civil war going on inside every one of the 37 trillion cells in your body. Now, University of Michigan scientists have uncovered how your cells keep this war from causing too much collateral damage.

26 Apr 2014

Graphene may lead to new applications in the diagnosis and treatment of neurological diseases

The development of graphene-a highly advanced metamaterial with many unique and varied properties-may lead to exciting new applications in the diagnosis and treatment of neurological diseases, according to a report in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

26 Apr 2014

MGH investigators develop next-generation genome editing system

A next-generation genome editing system developed by Massachusetts General Hospital investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication in Nature Biotechnology, the researchers report a new CRISPR-based RNA-guided nuclease technology that uses two guide RNAs, significantly reducing the chance of cutting through DNA strands at mismatched sites.

26 Apr 2014

FDA proposes rule to include e-cigarettes under its tobacco authority

The U.S. Food and Drug Administration (FDA) has recently proposed a new rule to regulate additional tobacco products as part of its implementation of the 2009 Family Smoking Prevention and Tobacco Control Act.

25 Apr 2014

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both drug-sensitive and some forms of multi-drug resistant tuberculosis (TB) to a global Phase 3 clinical trial.

25 Apr 2014

NeoGenomics' revenue up 16.1% in first quarter 2014

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the first quarter of 2014.

23 Apr 2014

Courtagen collaborates with CCMC to identify alterations in genes associated with ASD

Courtagen Life Sciences, Inc., an innovative molecular information company, announced today a collaboration with Connecticut Children's Medical Center to utilize Courtagen's sophisticated Next Generation Sequencing assays to help identify and characterize alterations found in genes associated with ASD.

23 Apr 2014

IMPAKT breast cancer conference abstracts online

Xenografts and mathematical modelling; liquid biopsy; nanotechnology; next generation genomics- Science is running fast and the impact of new technologies in the care of patients with breast cancer will be at the core of the sixth edition of the IMPAKT conference on translational research in breast cancer.

22 Apr 2014

WOTV 4's Maranda and Forest Hills Central students honored for contributing to community-based causes

The second annual Carol Van Andel Angel of Excellence dinner and award presentation took place on April 17, 2014. The event, hosted by Van Andel Institute (VAI), honored individuals who have made a significant contribution to the Institute through volunteer service, philanthropy, special event support, innovation or scientific support.

18 Apr 2014

Cyclenium Pharma signs drug discovery and development agreement with Southern Research Institute

Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the research and development of novel drug candidates based on proprietary macrocyclic chemistry, today announced the signing of a discovery and co-development agreement with Southern Research Institute, a not-for-profit 501(c)(3) scientific research organization founded in 1941.

18 Apr 2014

13th annual Bio-IT World Conference & Expo to launch new disciplinary track on data security

The 13th annual Bio-IT World Conference & Expo, to be held April 29-May 1 at the Seaport World Trade Center in Boston, today announced that it will debut a new disciplinary track focused on data security.

18 Apr 2014

Next Generation News and Research

Compounds in soy sauce can be 70 times more potent than first-line HIV drug Tenofovir

Olympus launches next-generation ENDOCAPSULE 10 System for capsule endoscopy procedures

ASGE to honor important contributions to field of endoscopy during tenth annual ASGE Crystal Awards

New research shows UK has highest infant mortality rates in Western Europe

Sleep habits associated with memory in old-age

Illumina launches VeriSeq PGS for preimplantation genetic screening of embryos

EGPAF launches new training program to address health care worker shortages in Malawi

Mayo Clinic launches new gene panel cancer test to help tailor chemotherapy

Voluntis closes €20.75 million ($29 million) Series D financing round

University of Michigan scientists uncover how cells block mutation-causing activity of junk DNA

Graphene may lead to new applications in the diagnosis and treatment of neurological diseases

MGH investigators develop next-generation genome editing system

FDA proposes rule to include e-cigarettes under its tobacco authority

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

NeoGenomics' revenue up 16.1% in first quarter 2014

Courtagen collaborates with CCMC to identify alterations in genes associated with ASD

IMPAKT breast cancer conference abstracts online

WOTV 4's Maranda and Forest Hills Central students honored for contributing to community-based causes

Cyclenium Pharma signs drug discovery and development agreement with Southern Research Institute

13th annual Bio-IT World Conference & Expo to launch new disciplinary track on data security

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News